✦ LIBER ✦

Long-term immunogenicity and efficacy of a 9-valent conjugate pneumococcal vaccine in human immunodeficient virus infected and non-infected children in the absence of a booster dose of vaccine

✍ Scribed by Shabir A. Madhi; Peter Adrian; Locadiah Kuwanda; Wasilla Jassat; Stephanie Jones; Tessa Little; Anu Soininen; Clare Cutland; Keith P. Klugman

Book ID: 116959284
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 125 KB
Volume: 25
Category: Article
ISSN: 0264-410X
DOI: 10.1016/j.vaccine.2006.09.019

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The immunogenicity and safety of pneumoc

The immunogenicity and safety of pneumococcal conjugate vaccine in human immunodeficiency virus-infected Thai children

✍ Chareeya Thanee; Chitsanu Pancharoen; Sasithorn Likitnukul; Voravich Luangwedcha 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 216 KB

Corrigendum to “The immunogenicity and s

Corrigendum to “The immunogenicity and safety of pneumococcal conjugate vaccine in human immunodeficiency virus-infected Thai children” [Vaccine 29 (2011) 5886–5891]

✍ Chareeya Thanee; Chitsanu Pancharoen; Sasithorn Likitnukul; Voravich Luangwedcha 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 87 KB

Immunogenicity and serotype-specific eff

Immunogenicity and serotype-specific efficacy of a 9-valent pneumococcal conjugate vaccine (PCV-9) determined during an efficacy trial in The Gambia

✍ M. Saaka; B.J. Okoko; R.C. Kohberger; S. Jaffar; G. Enwere; E.E. Biney; C. Oluwa 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 500 KB

Antibody titers eight months after three

Antibody titers eight months after three doses of a five-valent pneumococcal conjugate vaccine in HIV and non-HIV-infected children less than two years of age

✍ James C. King Jr; Peter E. Vink; Ih Chang; Alan Kimura; Marie Parks; Martha Smil 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 698 KB

Safety of the 11-valent pneumococcal vac

Safety of the 11-valent pneumococcal vaccine conjugated to non-typeable Haemophilus influenzae-derived protein D in the first 2 years of life and immunogenicity of the co-administered hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated polio virus, Haemophilus influenzae type b and control hepatitis A vaccines

✍ Roman Prymula; Roman Chlibek; Miroslav Splino; Eva Kaliskova; Igor Kohl; Patrici 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 325 KB